Psytelligence is a psychedelic industry consultancy and media company founded by Eric Shumake and Rebecca Zimmerman. With its finger on the pulse of the latest developments in the psychedelic space, Psytelligence offers insights into this emerging sector’s rapid growth and evolution.
Through its newsletter and website, Psytelligence provides analysis of breaking news, clinical trials, investment trends, and psychedelic science. The company has become a resource for anyone looking to stay current on the opportunities and innovations arising in the psychedelic field.
In addition to its media offerings, Psytelligence provides specialized consultancy services to new and established players in the industry. With expertise spanning drug development, policy and regulations, business strategy, and more, the Psytelligence team offers tailored guidance and support to help psychedelic companies and organizations navigate complex challenges and capitalize on new possibilities.
Led by veteran psychedelic entrepreneurs Shumake and Zimmerman, Psytelligence is driven by a vision of developing a more intelligent, more conscious, and ethically-oriented psychedelic ecosystem.
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates